Novel markers to predict virological and clinical relapse onset following antiviral treatment discontinuation in chronic hepatitis B patients | ||
| EASL 2020 Aug 27-29 virtual Reported by Jules Levin M.TUEFFERD1, M. CRABBE1, TH HU2, CY CHEN3, RN CHIEN4, KL WEI5, CY PENG6, WL CHUANG7, WW SU8, KH LIANG9,10, A SHEN1, YS LIN1, A DI CARA11, J BOLLEKENS1, CT YEH12, K SPITTAELS1, J AERSSENS1 1Janssen Pharmaceutica, Johnson & Johnson Pharmaceutical Research & Development 2Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan 3Chia-Yi Christian Hospital, Chia-Yi, Taiwan 4Linkou Chang Gung Memorial Hospital and University, Taoyuan, Taiwan 5Chiayi Chang-Gung Memorial Hospital, Chiayi, Taiwan 6China Medical University Hospital, Taichung, Taiwan 7Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 8Chang-Hua Christian Hospital, Chang-Hua, Taiwan 9Medical Research Department, Taipei Veterans General Hospital, Taipei, Taiwan 10Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan 11Precision for Medicine, Geneva, Switzerland 12Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan          | ||
